Advances in Mechanism of Traditional Chinese Medicines and Its Active Ingredients Treating Dyslipidemia
10.13422/j.cnki.syfjx.20202037
- VernacularTitle:中药有效成分对血脂异常作用机制的研究进展
- Author:
Xiu-chao GENG
1
;
Yu-hao ZHANG
2
;
Jia-xing JING
1
;
Zhong-rui ZHU
1
;
Qiang LI
1
;
Wen-tao YU
1
Author Information
1. Faculty of Integrated Traditional Chinese and Western Medicine,School of Basic Medicine, Faculty of Acupuncture-Moxibustion and Tuina, Hebei University of Chinese Medicine, Shijiazhuang 050200, China
2. School of Medicine, Hebei University, Baoding 071000, China
- Publication Type:Research Article
- Keywords:
dyslipidemia;
active ingredients of traditional chinese medicine;
targets;
mechanism of action;
advance
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(20):213-220
- CountryChina
- Language:Chinese
-
Abstract:
Dyslipidemia is a disease of lipid metabolism. At present, the prevalence of dyslipidemia in adults in China is as high as 40.40%. In the United States, there are more than 100 million individuals with abnormal low-density lipoprotein cholesterol (LDL-C), and the incidence rate is increasing year by year and showing a trend of becoming younger. Dyslipidemia is closely related to a variety of diseases such as fatty liver, atherosclerosis , hypertension, coronary heart disease, diabetes, and stroke. It has now developed into a global public health problem that seriously threatens human life and health. Modern medicine believes that its pathogenesis is complicated and is related to abnormal glucose and lipid metabolism, insulin resistance (IR) and other factors. Chinese medicine ascribes it to primary asthenia-secondary sthenia syndrome, which is closely related to the liver, spleen, and kidney. It is believed that excessive fat and grease can cause phlegm and cause many diseases. In terms of its treatment, western medicine mainly uses statin chemical synthesis preparations, with stable therapeutic effect, but many adverse reactions such as myalgia, myositis, rhabdomyolysis and acute renal injury are the main factors restricting its clinical application. Traditional Chinese medicine (TCM) has a long history, and multi-pathway, multi-target, multi-level regulation of dyslipidemia, few adverse reactions and low drug dependence are the principal advantages of TCM in treating dyslipidemia. At present, there are more and more researches on the prevention and treatment of dyslipidemia by TCM, but they are mainly focused on the observation of curative effect and the summary of prescription, and there are relatively few in-depth discussion and summary of the mechanism of TCM. Through comprehensively retrieving and collating the relevant domestic and foreign literatures in the past five years, we reviews from the perspective of effective ingredients, therapeutic pathways, and targets of action, and comprehensively introduces the latest research progress of TCM on the mechanism of regulating dyslipidemia, and put forward some suggestions for the possible research direction in the future, in order to provide new ideas and theoretical basis for TCM in clinical prevention and treatment of this disease.
